In this Issue:
Colonic endoscopy for differentiating CD and UC
Pharmacological VTE prophylaxis in hospitalised severe active UC
Serum infliximab concentration and efficacy in luminal CD
Mortality after hospitalisation for UC
Adalimumab combinations, not monotherapy, increase malignancy risk
Methotrexate + infliximab no better than infliximab alone in CD
Budesonide better than mesalamine/placebo in collagenous colitis
Etrolizumab as induction UC therapy
Collagen degradation and neutrophilic infiltration
Budesonide MMX® in active, mild-to-moderate UC
Please login below to download this issue (PDF)